Cargando…

Characterisation of a novel A1-specific monoclonal antibody

Detalles Bibliográficos
Autores principales:	Lang, M J, Brennan, M S, O'Reilly, L A, Ottina, E, Czabotar, P E, Whitlock, E, Fairlie, W D, Tai, L, Strasser, A, Herold, M J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649835/ https://www.ncbi.nlm.nih.gov/pubmed/25476901 http://dx.doi.org/10.1038/cddis.2014.519

Ejemplares similares

Evidence against upstream regulation of the unfolded protein response (UPR) by pro-apoptotic BIM and PUMA
por: Herold, M J, et al.
Publicado: (2014)

The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy
por: Hudson, R, et al.
Publicado: (2005)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules
por: Rees, Jennifer, et al.
Publicado: (2017)

Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
por: Tibble, Holly, et al.
Publicado: (2023)

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
por: Arora, Prerna, et al.
Publicado: (2023)

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
por: Berry, Jody D, et al.
Publicado: (2004)

Characterising neuropsychiatric disorders in patients with COVID-19
por: Oldham, Mark A, et al.
Publicado: (2020)

Production and characterisation of a monoclonal antibody (Cx-99) against cervical carcinoma.
por: Yuan, C. C., et al.
Publicado: (1992)

The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA—A Case Series
por: O’Reilly, Aoife, et al.
Publicado: (2021)

Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival
por: Sochalska, M, et al.
Publicado: (2016)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
por: Bruynck, A., et al.
Publicado: (1993)

Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
por: Parikh, Sameer A., et al.
Publicado: (2022)

Fulvestrant-Big Mac Index: Defining Inequality in Oncology
por: O'Reilly, David, et al.
Publicado: (2021)

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
por: Yamasoba, Daichi, et al.
Publicado: (2022)

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022)

Treatment of Refractory Prurigo Nodularis with a Monoclonal Antibody Dupilumab with Surprising Clinical Response
por: Alves, Juliana P., et al.
Publicado: (2023)

The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophils
por: Schenk, Robyn L., et al.
Publicado: (2020)

Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’
por: Dankner, Matthew, et al.
Publicado: (2018)

Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody
por: Tan, Lu, et al.
Publicado: (2015)

Limits of Monoclonal Antibody Treatment in Pregnant Women Complicated with COVID-19 Due to The Omicron Variant
por: Cha, Hyun-Hwa, et al.
Publicado: (2022)

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
por: Mejstríková, E., et al.
Publicado: (2017)

Development of an anti-ferret CD4 monoclonal antibody for the characterisation of ferret T lymphocytes
por: Layton, Daniel S., et al.
Publicado: (2017)

Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
por: Raghu, Ganesh, et al.
Publicado: (2022)

Genomic characterisation of human monkeypox virus in Nigeria
por: Faye, Ousmane, et al.
Publicado: (2018)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Two long-lasting human monoclonal antibodies cross-react with monkeypox virus A35 antigen
por: Zhou, Bing, et al.
Publicado: (2023)

The diffusion of a tumour-specific monoclonal antibody in lymphoma infiltrated spleen.
por: Cobb, L. M., et al.
Publicado: (1987)

A transgenic mouse model to inducibly target prosurvival Bcl2 proteins with selective BH3 peptides in vivo
por: Lee, E F, et al.
Publicado: (2015)

Medial Tentorial Meningeal Supply from the Collicular Artery: Anatomy and Endovascular Implications
por: O’Reilly, Sean Thomas, et al.
Publicado: (2023)

Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
por: Rowe, D. J., et al.
Publicado: (1984)

A monoclonal antibody specifically reactive with Ewing's sarcoma.
por: Hara, S., et al.
Publicado: (1989)

Diagnosis of Mycoplasma pneumoniae Pneumonia with Measurement of Specific Antibody-Secreting Cells
por: Meyer Sauteur, Patrick M., et al.
Publicado: (2019)

Generation and Characterisation of Monoclonal Antibodies against Nairobi Sheep Disease Virus Nucleoprotein
por: Maze, Emmanuel A., et al.
Publicado: (2023)

Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies
por: Carillo, Sara, et al.
Publicado: (2020)

Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study''
por: Shinozaki, Eiji, et al.
Publicado: (2018)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein–ACE2 interaction
por: Yuan, MengYa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fi50t5o9j2d8fehmoc91qq83me